This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Darras-Joly, C.
Right arrow Articles by Azoulay-Dupuis, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Darras-Joly, C.
Right arrow Articles by Azoulay-Dupuis, E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Sep 1996, 2147-2151, Vol 40, No. 9
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model

C Darras-Joly, JP Bedos, C Sauve, P Moine, E Vallee, C Carbon and E Azoulay-Dupuis
Institut National de la Sante et de la Recherche Medicale U 13, Paris, France.

In vivo synergy with beta-lactam antibiotics and aminoglycosides has been studied only with penicillin-susceptible Streptococcus pneumoniae strains. We evaluated the interaction between amoxicillin (AMX) and gentamicin (GEN) on the basis of in vitro checkerboard and time-kill curves and of findings in a mouse model of acute bacteremic pneumonia due to a highly penicillin-resistant and -tolerant S. pneumoniae strain of serotype 19 (penicillin and AMX MICs of 4 micrograms/ml; gentamicin MIC of 16 micrograms/ml). Checkerboard results at 18 h of incubation showed indifference. With regard to AMX alone, in vitro time-kill curves demonstrated synergy between AMX (1 microgram/ml) and GEN (16 micrograms/ml) at 5 and 8 h of incubation and for AMX (16 micrograms/ml) in combination with GEN (16 micrograms/ml) at 3, 5, and 8 h of incubation. In leukopenic mice, pulmonary killing curves after a single drug injection demonstrated that AMX (100 mg/kg of body weight) with GEN (16 mg/kg) was more effective than AMX alone (P = 10(-4). With repeated-dose treatment, a synergy was apparent at 8 h after four injections with AMX (100 mg/kg) in combination with GEN (8 or 16 mg/kg) (P < or = 0.05). The cumulative survival rate with AMX (100 mg/kg) every 8 h, combined with GEN (4 or 8 mg/kg) every 8, 12, or 24 h, was better than with AMX alone. Combined use of AMX and GEN may be a valuable therapeutic alternative for pneumococcal pneumonia due to highly penicillin-resistant S. pneumoniae strains.


This article has been cited by other articles:

  • Abgueguen, P., Azoulay-Dupuis, E., Noel, V., Moine, P., Rieux, V., Fantin, B., Bedos, J.-P. (2007). Amoxicillin Is Effective against Penicillin-Resistant Streptococcus pneumoniae Strains in a Mouse Pneumonia Model Simulating Human Pharmacokinetics. Antimicrob. Agents Chemother. 51: 208-214 [Abstract] [Full Text]  
  • Gracia, M., Martinez-Marin, C., Huelves, L., Gimenez, M. J., Aguilar, L., Carcas, A., Ponte, C., Soriano, F. (2005). Pulmonary Damage and Bacterial Load in Assessment of the Efficacy of Simulated Human Treatment-Like Amoxicillin (2,000 Milligrams) Therapy of Experimental Pneumococcal Pneumonia Caused by Strains for Which Amoxicillin MICs Differ. Antimicrob. Agents Chemother. 49: 996-1001 [Abstract] [Full Text]  
  • Cottagnoud, P., Gerber, C. M., Cottagnoud, M., Tauber, M. G. (2002). Gentamicin Increases the Efficacy of Vancomycin against Penicillin-Resistant Pneumococci in the Rabbit Meningitis Model. Antimicrob. Agents Chemother. 46: 188-190 [Abstract] [Full Text]  
  • Johansen, H. K., Jensen, T. G., Dessau, R. B., Lundgren, B., Frimodt-Moller, N. (2000). Antagonism between penicillin and erythromycin against Streptococcus pneumoniae in vitro and in vivo. J Antimicrob Chemother 46: 973-980 [Abstract] [Full Text]  
  • Schrag, S. J., Beall, B., Dowell, S. F. (2000). Limiting the Spread of Resistant Pneumococci: Biological and Epidemiologic Evidence for the Effectiveness of Alternative Interventions. Clin. Microbiol. Rev. 13: 588-601 [Abstract] [Full Text]  
  • Piroth, L., Martin, L., Coulon, A., Lequeu, C., Duong, M., Buisson, M., Portier, H., Chavanet, P. (1999). Development of a New Experimental Model of Penicillin-Resistant Streptococcus pneumoniae Pneumonia and Amoxicillin Treatment by Reproducing Human Pharmacokinetics. Antimicrob. Agents Chemother. 43: 2484-2492 [Abstract] [Full Text]  
  • Ogtrop, M. L. v. (1999). The antibacterial efficacy of trovafloxacin against an experimental infection with Listeria monocytogenes in hydrocortisone-treated mice. J Antimicrob Chemother 44: 229-234 [Abstract] [Full Text]  
  • Tateda, K., Matsumoto, T., Miyazaki, S., Yamaguchi, K. (1999). Efficacy of {beta}-lactam antibiotics combined with gentamicin against penicillin-resistant pneumococcal pneumonia in CBA/J mice. J Antimicrob Chemother 43: 367-371 [Abstract] [Full Text]